Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Nephron Pharmaceuticals Appoints Haywood Miller as Interim Chief Executive Officer

PRIVATEOct 16, 2026

Position

Chief Executive Officer

Company

Nephron Pharmaceuticals

Haywood Miller
West ColumbiaBiotechnologyHealth CarePharmaceutical

Description

Nephron Pharmaceuticals announced the departure of Lou Kennedy from her position as Chief Executive Officer. Haywood Miller has been appointed as the Interim Chief Executive Officer, effective immediately.

Company Information

Company

Nephron Pharmaceuticals

Location

West Columbia, South Carolina, United States

About

Nephron Pharmaceuticals, founded in 1997 by Lou and Bill Kennedy, is a leading provider of generic respiratory and 503B outsourcing medications. The Company specializes in sterile dose medications and compounded solutions, developing, testing, producing, and shipping high volumes of sterile drugs. Nephron serves wholesalers, retailers, and hospitals nationwide, addressing drug shortages and strengthening the healthcare system.

Fundz sees it the moment Nephron Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Christopher
Likely contact at this company
••••••••@••••••••

See Christopher's verified email →

Kayla
Likely contact at this company
••••••••@••••••••

See Kayla's verified email →

Michelle
Likely contact at this company
••••••••@••••••••

See Michelle's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Nephron Pharmaceuticals's next move

Learn about Strategic plan

Nephron Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.